Lyra Health, which provides a mental wellness platform, filed paperwork to raise $175 million in Series E funding. The company set its value at $2.25 billion. It has previously received investments from Adams Street Partners, Tenaya Capital, Meritech Capital Partners, IVP, and Greylock.
The Lyra Health platform connects health plan members and their dependents to clinical professionals, mental health coaches, and personalized medication prescribing. Consumers complete an online assessment and are connected to a clinical professional, coach, or self-guided program tailored for the individual’s needs.
The filing was reported by Prime Unicorn Index, which tracks Lyra Health. The index provides data on private capital markets for institutional investors. The announcement noted that the Series E funding round is on top of $110 million raised for Series D, which valued Lyra Health at $1.06 billion. Lyra Health’s share price has nearly doubled between the two funding rounds, from $14.21 during the Series D funding round to $27.47 at the Series E funding.
This was reported by Prime Unicorn Index on December 17, 2020.
Contact information: Press and Media Relations, Lyra Health, 287 Lorton Avenue, Burlingame, CA 94010; Email: press@lyrahealth.com; Website: https://www.lyrahealth.com/contact/.
Contact information: Prime Unicorn Index, 646-290-9254; Email: contact@primeunicornindex.com; Website: https://primeunicornindex.com/contact/
